Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial
- Status
- UNKNOWN
- Phase
- PHASE3
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant Therapy in Biliary Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
- Status
- TERMINATED
- Phase
- PHASE3
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
- Status
- RECRUITING
- Phase
- PHASE3
Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2